Fund profile
Cowin Ventures
China
Leading
About
Co-Win Ventures, founded in 2009 and based in Beijing, China, is a prominent early-stage investment firm focusing on the Technology, Media, and Telecommunications (TMT) and healthcare sectors. Their portfolio features a variety of innovative companies, including KBP Biosciences, Celsius Therapeutics, Thrive Earlier Detection, and Fluent BioSciences. The firm supports both early-stage and growth-stage companies, providing capital and strategic guidance to help them scale successfully. Co-Win Ventures has a strong presence in both China and the USA, leveraging its extensive network to foster innovation and growth. Their investment approach combines financial backing with hands-on support, ensuring that their portfolio companies have the resources they need to thrive in competitive markets. By focusing on sectors with high growth potential, Co-Win Ventures aims to drive advancements in technology and healthcare, contributing to significant industry developments. Their commitment to supporting visionary entrepreneurs has made them a key player in the venture capital landscape.
Details
Highlights
$1.1M
Historical average check
$24M
Historical max check
March 2024
Last investment date
79
Investments
Healthtech & Wellness
Hardware. Robotics & IoT
Software & Apps
Other
Showing 0 lists
Contacts
Lists that include this fund